Literature DB >> 29455313

[18F]FDG PET/MR enterography for the assessment of inflammatory activity in Crohn's disease: comparison of different MRI and PET parameters.

Yan Li1, Karsten Beiderwellen2,3, Felix Nensa2, Johannes Grüneisen2, Gustav Dobos4, Ken Herrmann5, Thomas Lauenstein2,6, Lale Umutlu2, Jost Langhorst4.   

Abstract

PURPOSE: To evaluate the diagnostic performance of integrated whole-body positron emission tomography (PET)/magnetic resonance (MR) enterography in patients with Crohn's disease (CD).
METHODS: Fifty patients with known CD and recurrent symptoms underwent ileocolonoscopy (reference standard) as well as PET/MR enterography. Seven ileocolonic segments were endoscopically analysed using the Simplified Endoscopic Activity Score for Crohn's Disease (SES-CD) and additionally classified into three categories of inflammation (none, mild to moderate and severe ulcerative inflammation). A total of 14 PET/MR parameters were applied for the assessment of inflamed segments. Contingency tables and the chi-squared test were used for the analysis of qualitative parameters, and the Mann-Whitney U test and receiver operating characteristic (ROC) curve for the analysis of quantitative parameters. The PET/MR parameters were ranked according to their diagnostic value by random forest classification. Correlations between PET/MR parameters and the severity of inflammation on endoscopy and SES-CD were tested using Spearman's rank correlation test.
RESULTS: A total of 309 segments could be analysed. Based on multivariate regression analysis, wall thickness and the comb sign were the most important parameters for predicting segments with active inflammation of any type. SUVmax ratio of the bowel segment (relative to SUVmax of the liver) was the most important parameter for detecting segments with severe ulcerative inflammation. Wall thickness was the only parameter that moderately correlated with inflammation severity on endoscopy as well as with SES-CD (ρ = 0.56 and 0.589, both p < 0.001).
CONCLUSION: PET/MR enterography is an excellent noninvasive diagnostic method, and both MR parameters and PET findings provided high accuracy in detecting inflamed segments.

Entities:  

Keywords:  Crohn’s disease; IBD; MR enterography; PET/MR

Mesh:

Substances:

Year:  2018        PMID: 29455313     DOI: 10.1007/s00259-018-3962-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  28 in total

1.  Low-dose 18F-FDG PET/CT enterography: improving on CT enterography assessment of patients with Crohn disease.

Authors:  Paul B Shyn; Koenraad J Mortele; Scott H Britz-Cunningham; Sonia Friedman; Robert D Odze; Robert Burakoff; Joel E Goldberg; Mehmet Erturk; Stuart G Silverman
Journal:  J Nucl Med       Date:  2010-11-15       Impact factor: 10.057

2.  Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn's disease.

Authors:  Riccardo Del Vescovo; Ilaria Sansoni; Renato Caviglia; Mentore Ribolsi; Giuseppe Perrone; Emanuele Leoncini; Rosario Francesco Grasso; Michele Cicala; Bruno Beomonte Zobel
Journal:  Abdom Imaging       Date:  2008 Jul-Aug

3.  Noninvasive assessment of pediatric inflammatory bowel disease with ¹⁸F-fluorodeoxyglucose-positron emission tomography and computed tomography.

Authors:  Jan Däbritz; Niklas Jasper; Markus Loeffler; Matthias Weckesser; Dirk Foell
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 2.566

4.  Improved detection of inflammatory bowel disease by additional automated motility analysis in magnetic resonance imaging.

Authors:  Maria L Hahnemann; Felix Nensa; Sonja Kinner; Stefan Maderwald; Lale Umutlu; Guido Gerken; Thomas C Lauenstein
Journal:  Invest Radiol       Date:  2015-02       Impact factor: 6.016

5.  Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines.

Authors:  J Panes; Y Bouhnik; W Reinisch; J Stoker; S A Taylor; D C Baumgart; S Danese; S Halligan; B Marincek; C Matos; L Peyrin-Biroulet; J Rimola; G Rogler; G van Assche; S Ardizzone; A Ba-Ssalamah; M A Bali; D Bellini; L Biancone; F Castiglione; R Ehehalt; R Grassi; T Kucharzik; F Maccioni; G Maconi; F Magro; J Martín-Comín; G Morana; D Pendsé; S Sebastian; A Signore; D Tolan; J A Tielbeek; D Weishaupt; B Wiarda; A Laghi
Journal:  J Crohns Colitis       Date:  2013-04-11       Impact factor: 9.071

6.  Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index.

Authors:  Michael J Steward; Shonit Punwani; Ian Proctor; Yvette Adjei-Gyamfi; Fiona Chatterjee; Stuart Bloom; Marco Novelli; Steve Halligan; Manuel Rodriguez-Justo; Stuart A Taylor
Journal:  Eur J Radiol       Date:  2011-09-15       Impact factor: 3.528

7.  Evaluation of diffusion-weighted MR imaging for detection of bowel inflammation in patients with Crohn's disease.

Authors:  Aytekin Oto; Fang Zhu; Kirti Kulkarni; Gregory S Karczmar; Jerrold R Turner; David Rubin
Journal:  Acad Radiol       Date:  2009-03-17       Impact factor: 3.173

8.  18F-Fluorodeoxyglucose positron-emission tomography (PET) can be used to assess inflammation non-invasively in Crohn's disease.

Authors:  Martin H Holtmann; Manuela Uenzen; Andreas Helisch; Anja Dahmen; Jonas Mudter; Martin Goetz; Mathias Schreckenberger; Peter R Galle; Peter Bartenstein; Markus F Neurath
Journal:  Dig Dis Sci       Date:  2012-05-09       Impact factor: 3.199

9.  Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies.

Authors:  M F Neurath; D Vehling; K Schunk; M Holtmann; H Brockmann; A Helisch; T Orth; M Schreckenberger; P R Galle; P Bartenstein
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

10.  PET/CT colonography: a novel non-invasive technique for assessment of extent and activity of ulcerative colitis.

Authors:  Chandan J Das; Govind K Makharia; Rakesh Kumar; Rajender Kumar; Rajeew P Tiwari; Raju Sharma; Arun Malhotra
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-22       Impact factor: 9.236

View more
  4 in total

1.  18F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis: a randomized controlled trial.

Authors:  Yan Li; Benedikt Schaarschmidt; Lale Umutlu; Michael Forsting; Aydin Demircioglu; Anna Katharina Koch; Ole Martin; Ken Herrmann; Hendrik Juette; Andrea Tannapfel; Jost Langhorst
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-10-24       Impact factor: 9.236

2.  Assessment of Ileocolonic Inflammation in Crohn's Disease: Which Surrogate Marker Is Better-MaRIA, Clermont, or PET/MR Index? Initial Results of a Feasibility Trial.

Authors:  Yan Li; Jost Langhorst; Anna Katharina Koch; Aydin Demircioglu; Felix Nensa; Julian Kirchner; Karsten Beiderwellen; Onofrio Catalano; Michael Forsting; Ken Herrmann; Lale Umutlu
Journal:  J Nucl Med       Date:  2018-11-02       Impact factor: 10.057

3.  Comparison of 18F-FDG PET-MR and fecal biomarkers in the assessment of disease activity in patients with ulcerative colitis.

Authors:  Yan Li; Michael Khamou; Benedikt Michael Schaarschmidt; Lale Umutlu; Michael Forsting; Aydin Demircioglu; Johannes Haubold; Anna Katharina Koch; Nils-Martin Bruckmann; Lino Morris Sawicki; Ken Herrmann; James Hunter Boone; Jost Langhorst
Journal:  Br J Radiol       Date:  2020-06-24       Impact factor: 3.039

4.  Initial Experience With Low-Dose 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging With Deep Learning Enhancement.

Authors:  Christian J Park; Weijie Chen; Ali Pirasteh; David H Kim; Scott B Perlman; Jessica B Robbins; Alan B McMillan
Journal:  J Comput Assist Tomogr       Date:  2021 Jul-Aug 01       Impact factor: 1.826

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.